ARCH Venture Partners X Discloses 12.9% Stake in Aspen Neuroscience
ARCH Venture Partners X and affiliated funds disclosed a 12.9% stake in Aspen Neuroscience, equal to 3.75 million shares. They acquired 1.33 million shares at $15 each during the IPO on Nov. 2, 2026. The group stated its investment is for long-term purposes with no immediate plans to alter the company's business or control.
